clomipramine has been researched along with buspirone in 32 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.13) | 18.7374 |
1990's | 16 (50.00) | 18.2507 |
2000's | 6 (18.75) | 29.6817 |
2010's | 9 (28.13) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barr, LC; Goodman, WK; Price, LH | 1 |
Hart, LL; Maruno, CA | 1 |
Gluhoski, V; Pato, MT | 1 |
Bernstein, SE; Bihari, K; Hill, JL; L'Heureux, F; Murphy, DL; Pigott, TA | 1 |
Murphy, DL; Pato, MT; Pigott, TA | 1 |
Bernstein, S; Grover, GN; Hill, JL; Murphy, DL; Pato, MT; Pigott, TA | 1 |
Futuro-Neto, HA; Pires, JG; Silva, SR | 1 |
Caruso, J; Molino, LJ; Shemer, AV; Whitaker-Azmitia, PM | 1 |
Goodman, WK; McDougle, CJ; Price, LH | 1 |
Katz, G; Nijhawan, PK; Winter, S | 1 |
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
Bejerot, S; Bodlund, O | 1 |
Dimitriou, CE; Dimitriou, EC | 1 |
Dodman, NH; Moon-Fanelli, AA; Sawyer, LS | 1 |
Trappler, B | 1 |
Ninan, PT | 1 |
Juarbe-Díaz, SV | 1 |
Maaswinkel, H; Weng, W; Zhu, L | 1 |
7 review(s) available for clomipramine and buspirone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Buspirone in obsessive-compulsive disorder.
Topics: Adult; Buspirone; Clinical Trials as Topic; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder | 1992 |
Serotonin and effect sizes of antiobsessive agents.
Topics: Buspirone; Clinical Trials as Topic; Clomipramine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 1992 |
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Pyrimidines; Serotonin Antagonists | 1990 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
The functional anatomy, neurochemistry, and pharmacology of anxiety.
Topics: Adrenergic Uptake Inhibitors; Amygdala; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clomipramine; Comorbidity; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Humans; Norepinephrine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 1999 |
4 trial(s) available for clomipramine and buspirone
Article | Year |
---|---|
A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
Topics: Adult; Analysis of Variance; Buspirone; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 1992 |
Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Pyrimidines; Serotonin Antagonists | 1990 |
Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Buspirone; Clomipramine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 1991 |
Buspirone augmentation of antidepressant therapy.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Depression; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Treatment Outcome | 1998 |
22 other study(ies) available for clomipramine and buspirone
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Acute exacerbation of body dysmorphic disorder during tryptophan depletion.
Topics: Acute Disease; Adult; Body Image; Buspirone; Clomipramine; Delusions; Female; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Tryptophan | 1992 |
Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Topics: Animals; Buspirone; Catalepsy; Chlorpromazine; Clomipramine; Female; Haloperidol; Male; Mice; Pindolol; Receptors, Serotonin | 1990 |
Serotonergic agents restore appropriate decision-making in neonatal rats displaying dopamine D1 receptor-mediated vacillatory behavior.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Animals, Newborn; Behavior, Animal; Buspirone; Clomipramine; Decision Making; Diazepam; Female; Pregnancy; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin | 1990 |
Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission.
Topics: Alcohol Withdrawal Delirium; Buspirone; Clomipramine; Diagnosis, Differential; Drug Therapy, Combination; Fluoxetine; Hospitalization; Humans; Male; Middle Aged; Myoclonus; Obsessive-Compulsive Disorder; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Serotonin; Syndrome | 1996 |
Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Citalopram; Clomipramine; Delusions; Drug Resistance; Female; Flupenthixol; Humans; Obsessive-Compulsive Disorder; Recurrence; Treatment Outcome | 1998 |
Psychogenic alopecia in cats: 11 cases (1993-1996).
Topics: Alopecia; Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Breeding; Buspirone; Cat Diseases; Cats; Clomipramine; Data Collection; Female; Grooming; Male; Retrospective Studies; Stress, Physiological | 1999 |
Treatment of obsessive-compulsive disorder using clomipramine in a very old patient.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Buspirone; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Heart Diseases; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 1999 |
Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Bird Diseases; Buspirone; Clomipramine; Drug Therapy, Combination; Feathers; Female; Grooming; Humans; Male; Obsessive-Compulsive Disorder; Parrots | 2000 |
The immediate and the delayed effects of buspirone on zebrafish (Danio rerio) in an open field test: a 3-D approach.
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Analysis of Variance; Animals; Anti-Anxiety Agents; Buspirone; Clomipramine; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Freezing Reaction, Cataleptic; Imaging, Three-Dimensional; Movement; Selective Serotonin Reuptake Inhibitors; Time Factors; Zebrafish | 2012 |